4.7 Review

Ovarian cancer stem cell markers: Prognostic and therapeutic implications

期刊

CANCER LETTERS
卷 322, 期 1, 页码 1-7

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2012.02.002

关键词

Cancer stem cells; Therapeutics; Ovarian cancer; Prognosis; Stem cell hierarchy

类别

资金

  1. NIGMS NIH HHS [T32 GM007315] Funding Source: Medline
  2. NIH HHS [DP2 OD004197] Funding Source: Medline

向作者/读者索取更多资源

Cancer stem cells are rare chemotherapy resistant cells within a tumor which can serve to populate the bulk of a tumor with more differentiated daughter cells and potentially contribute to recurrent disease. Ovarian cancer is a disease for which at the time of initial treatment we can obtain complete clinical remission in the majority of patients. Unfortunately, most will relapse and succumb to their disease. This clinical course is in line with the cancer stem cell model. In the past 5 years a significant amount of work has been done to identify cells with characteristics of ovarian cancer stem cells. This review will focus specifically on the markers used to define human ovarian cancer stem cells, the prognostic implications of the expression of these cancer stem cell markers in patient's primary tumors, and the potential of these cancer stem cell markers to serve as therapeutic targets. (C) 2012 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据